|
| For Faculty and Staff of Emory University | |
| |
|
|
| | | | | COVID-19 in class: Lessons from the pandemic | | Courses across Emory have pivoted to examine COVID-19 as a real-time learning experience. Whether discussing crisis management, studying effects on air pollution, hearing from health care providers or collecting supplies to support them, students are learning extraordinary lessons in an extraordinary time. | |
| | | |
| | | |
| | | | | | FDA says human trials can begin for Emory COVID-19 antiviral | | An oral antiviral discovered and developed at Emory has received FDA approval to begin human trials in the U.S. The compound, EIDD-2801, has shown promise as a potential treatment for COVID-19. | |
|
|
|
|
|
| EMORY EXPERTS ON COVID-19 |
| | | |
| | | |
| | | |
| | | |
| | | |
|
|
|
|
|
|
| Editor: Laura Douglas-Brown Vice President for Enterprise Communications: Doug Busk Senior Vice President for Communications and Public Affairs: David B. Sandor
Emory Report is published by
Communications and Public Affairs Read the Emory Report Guidelines | | Copyright 2022 Emory University | All Rights Reserved 201 Dowman Drive, Atlanta, Georgia 30322 USA | 404.727.6123 | |
|
|